Latest filing published 08 Dec 2017 for PharMerica CORP.
No signal scores available.
Frank E. Collins is a declared insider of PharMerica Corp, with filings sourced from SEC (Form 4). Between 17 June 2016 and 7 December 2017, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 8 December 2017 with a transaction in PharMerica Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations